Logo

NTIC

Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation • NASDAQ
$7.44 ▼ -0.40% (-0.03)
Market Cap $70.50 M
52w High $14.75
52w Low $6.75
Dividend Yield 0.10%
P/E 24
Volume 34.43K
Outstanding Shares 9.48M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $22.315M ▲ $9.697M ▲ $-1.1M ▼ -4.927% ▼ $-0.12 ▼ $1.06M ▼
Q3-2025 $21.509M ▲ $9.665M ▲ $121.775K ▼ 0.566% ▼ $0.013 ▼ $1.354M ▼
Q2-2025 $19.072M ▼ $8.82M ▼ $434.319K ▼ 2.277% ▼ $0.046 ▼ $1.427M ▼
Q1-2025 $21.338M ▼ $9.47M ▼ $561.091K ▼ 2.629% ▼ $0.059 ▼ $1.547M ▼
Q4-2024 $23.349M $9.492M $1.836M 7.862% $0.19 $3.207M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $7.251M ▲ $102.745M ▲ $26.033M ▲ $72.149M ▼
Q3-2025 $6.773M ▲ $99.303M ▲ $22.727M ▲ $72.355M ▲
Q2-2025 $5.091M ▼ $93.695M ▼ $19.85M ▲ $69.746M ▼
Q1-2025 $5.57M ▲ $94.038M ▼ $19.731M ▲ $70.213M ▼
Q4-2024 $4.952M $94.677M $19.501M $71.194M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $332.451K ▼ $609.709K ▼ $-797.366K ▲ $1.78M ▲ $1.683M ▲ $-187.657K ▲
Q2-2025 $602.627K ▼ $803.675K ▼ $-1.322M ▼ $72.996K ▲ $-479.204K ▼ $-538.746K ▼
Q1-2025 $794.147K ▼ $2.395M ▲ $-1.258M ▼ $-393.341K ▼ $617.65K ▲ $1.137M ▲
Q4-2024 $2.213M ▲ $-1.701M ▼ $-817.052K ▲ $1.63M ▲ $-842.64K ▼ $-2.518M ▼
Q3-2024 $1.155M $1.941M $-1.095M $174.727K $959.793K $845.649K

Revenue by Products

Product Q3-2022Q4-2022Q3-2025Q4-2025
NaturTec
NaturTec
 $0 ▲$0 ▲$10.00M ▲$20.00M ▲
ZERUST
ZERUST
 $10.00M ▲$20.00M ▲$20.00M ▲$50.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has been climbing steadily over the past few years, which suggests the core business is gradually gaining traction. Profitability has been positive but not consistently strong, with some bumpiness in earnings from year to year. Margins look reasonable for a niche specialty chemicals company, but they don’t leave a huge cushion if conditions weaken. Overall, the income statement reflects a small but growing company that is moving in the right direction, while still sensitive to swings in demand and costs.

Balance Sheet

Balance Sheet The balance sheet looks relatively conservative. Assets and shareholders’ equity have been stable to slightly growing, indicating a business that is expanding without stretching itself too far. Debt exists but appears modest compared to the size of the company, suggesting leverage is manageable rather than aggressive. Cash levels have ticked down, which is worth watching, but there is no obvious sign of financial strain. In short, the company appears reasonably well-capitalized for its scale.

Cash Flow

Cash Flow Cash generation from the core business has recently turned more consistently positive, which supports the quality of reported earnings. Free cash flow is roughly around breakeven, helped by relatively light spending on equipment and facilities. This lean investment profile keeps cash needs modest, but it could also limit how quickly the company can scale if growth opportunities accelerate. Overall, cash flow looks adequate but not abundant, leaving some dependence on continued operational stability.

Competitive Edge

Competitive Edge NTIC operates in specialized corners of the chemicals market, focusing on corrosion prevention and biodegradable plastics. Its ZERUST brand in corrosion protection benefits from decades of experience, established customer relationships, and a reputation for reliability in demanding industries. The global network of partners and on-site technical consulting creates switching costs for customers, since solutions are tailored and service-intensive. In bioplastics, Natur-Tec rides structural trends toward sustainability, but faces a more crowded and fast-moving competitive field, where scale and cost efficiency are key. Together, these businesses give NTIC a distinctive niche, though not an unassailable position.

Innovation and R&D

Innovation and R&D Innovation is central to NTIC’s strategy. The company has built its business around proprietary corrosion-inhibiting chemistries and advanced bioplastic formulations, protected by a steady stream of patents. Its R&D is focused on improving performance, expanding use cases, and making products more sustainable, such as combining corrosion protection with biodegradable packaging. The ability to process bioplastics on standard equipment is a practical advantage for customers. Overall, NTIC’s research efforts appear targeted and commercially oriented, aimed at enhancing differentiation rather than broad, high-risk experimentation.

Summary

NTIC looks like a focused niche player combining industrial corrosion protection with environmentally friendly plastics. Financially, it shows gradual growth, modest but real profitability, and a generally conservative balance sheet, though with only moderate cash buffers. Cash flow is improving but still tight enough that consistent execution matters. Competitively, its strength lies in proprietary technologies, long-standing relationships, and a service-heavy model in corrosion control, while bioplastics offer growth potential but also bring more competition and regulatory and demand uncertainty. The company’s ongoing R&D and patent activity support its positioning, but its small scale means results can be more volatile than those of larger peers.

NEWS

November 4, 2025 · 8:00 AM UTC

Northern Technologies International Corporation Secures Multi-Year Offshore Oil & Gas Production Asset Preservation Contract in Brazil

Read more

October 15, 2025 · 8:00 AM UTC

Northern Technologies International Corporation Announces Quarterly Cash Dividend

Read more